UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 155

Sortiert nach

Ensaio Terapêutico com Heparina, Poliquimioterapia e Agentes Antifibrinolíticos em Casos de Tumores Sólidos Metastáticos

Revista Brasileira de Cancerologia, 2023-08, Vol.28 (2), p.23-27

2023

Volltextzugriff (PDF)

Dual Therapy based on Co-formulated darunavir/ritonavir plus lamivudine for initial therapy of HIV infection: the ANDES randomized controlled trial

International journal of antimicrobial agents, 2024-08, p.107301, Article 107301

2024

Volltextzugriff (PDF)

Viral and Microbial Pathogens, Indicator Microorganisms, Microbial Source Tracking Indicators, and Antibiotic Resistance Genes in a Confined Managed Effluent Recharge System

Journal of environmental engineering (New York, N.Y.), 2018-03, Vol.144 (3)

2018

Volltextzugriff (PDF)

The effect of protease inhibitor‐based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART‐naïve patients with HIV‐infection

HIV medicine, 2021-04, Vol.22 (4), p.254-261

2021

Volltextzugriff (PDF)

Bioinformatic analysis of post-transmission viral readaptation in Argentine patients with acute HIV-1 infection

Infection, genetics and evolution, 2020-07, Vol.81, p.104207-104207, Article 104207

2020

Volltextzugriff (PDF)

Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles

Heart (British Cardiac Society), 2005-02, Vol.91 (2), p.e10-e10

2005

Volltextzugriff (PDF)

Phenotype and functionality of CD8+ T cells before and after cART are related to the viral reservoir size in people living with HIV-1

Journal of Virus Eradication, 2019-07, Vol.5, p.4-4

2019

Volltextzugriff (PDF)

Early skewed differentiation and PD-1 expression in CD4+ cells relate to immune dysfunction and viral persistence in individuals living with HIV 1 year post-cART initiation

Journal of Virus Eradication, 2019-07, Vol.5, p.5-5

2019

Volltextzugriff (PDF)

Galectin-1 promotes HIV-1 latency reactivation

Journal of Virus Eradication, 2019-07, Vol.5, p.10-11

2019

Volltextzugriff (PDF)

HIV-1 infected patients older than 50 years. PISCIS cohort study

The Journal of infection, 2008-07, Vol.57 (1), p.64-71

2008

Volltextzugriff (PDF)

HIV, cardiovascular disease, and ageing

Journal of the International AIDS Society, 2013-06, Vol.16 (Suppl 1)

Sued, O

2013

Volltextzugriff (PDF)

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

The Lancet infectious diseases, 2014-07, Vol.14 (7), p.572-580

2014

Volltextzugriff (PDF)

Plasma cytokine levels and HIV-specific immune responses during acute/early HIV infection

Retrovirology, 2012-09, Vol.9 (S2), p.P265-P265, Article P265

2012

Volltextzugriff (PDF)

Use of darunavir and enfuvirtide in a pregnant woman

International journal of STD & AIDS, 2008-12, Vol.19 (12), p.866

2008

Volltextzugriff (PDF)

Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up

Journal of neurovirology, 2008, Vol.14 (6), p.474-479

2008

Volltextzugriff (PDF)

A global call for action to include gender in research impact assessment

Health research policy and systems, 2016-07, Vol.14 (1), p.50-50, Article 50

2016

Volltextzugriff (PDF)

Dual therapy (ritonavir boosted atazanavir + raltegravir) versus standard triple therapy (ritonavir boosted atazanavir + tenofovir/emtricitabine) in patients failing first line therapy: 48 week results from a randomized pilot study

International journal of infectious diseases, 2018-08, Vol.73, p.23-23

2018

Volltextzugriff (PDF)

Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI

The international journal of tuberculosis and lung disease, 2015-09, Vol.19 (9), p.1039

2015

Volltextzugriff (PDF)

Functionality of CD8+ T-cells in subjects under cART: implications on cure strategies

International journal of infectious diseases, 2018-08, Vol.73, p.85-86

2018

Volltextzugriff (PDF)

HIV and neglected infectious diseases in Latin America and the Caribbean: issues and challenges for knowing the burden of co-infection

Journal of the International AIDS Society, 2013-06, Vol.16 (Suppl 1)

2013

Volltextzugriff (PDF)

Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy

AIDS (London), 2006-01, Vol.20 (1), p.59-66

2006

Volltextzugriff (PDF)

Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain)

Journal of acquired immune deficiency syndromes (1999), 2008-02, Vol.47 (2), p.212

2008

Volltextzugriff (PDF)

Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality

Diagnostic microbiology and infectious disease, 2008-09, Vol.62 (1), p.34-43

2008

Volltextzugriff (PDF)

Self-reported cART adherence and alcohol, tobacco, and illicit drug use in a cohort of HIV-infected patients in Buenos Aires

Journal of the International AIDS Society, 2013-06, Vol.16 (Suppl 1)

2013

Volltextzugriff (PDF)

Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area

Transplantation, 2002-11, Vol.74 (10), p.1381

2002

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(22)
Science & Technology
(21)
Life Sciences & Biomedicine
(20)
Male
(15)
Adult
(14)
Female
(14)
Hiv
(14)
Infectious Diseases
(14)
Human Immunodeficiency Virus
(12)
Hiv Infections - Drug Therapy
(11)
Middle Aged
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Human Viral Diseases
(7)
Viral Diseases
(7)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(7)
Aids
(6)
Antiretroviral Therapy, Highly Active
(6)
Hiv Infections - Complications
(6)
Immunology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Ensaio Terapêutico com Heparina, Poliquimioterapia e Agentes Antifibrinolíticos em Casos de Tumores Sólidos Metastáticos

Dual Therapy based on Co-formulated darunavir/ritonavir plus lamivudine for initial therapy of HIV infection: the ANDES randomized controlled trial

Viral and Microbial Pathogens, Indicator Microorganisms, Microbial Source Tracking Indicators, and Antibiotic Resistance Genes in a Confined Managed Effluent Recharge System

The effect of protease inhibitor‐based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART‐naïve patients with HIV‐infection

Bioinformatic analysis of post-transmission viral readaptation in Argentine patients with acute HIV-1 infection

Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles

Phenotype and functionality of CD8+ T cells before and after cART are related to the viral reservoir size in people living with HIV-1

Early skewed differentiation and PD-1 expression in CD4+ cells relate to immune dysfunction and viral persistence in individuals living with HIV 1 year post-cART initiation

Galectin-1 promotes HIV-1 latency reactivation

HIV-1 infected patients older than 50 years. PISCIS cohort study

HIV, cardiovascular disease, and ageing

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

Plasma cytokine levels and HIV-specific immune responses during acute/early HIV infection

Use of darunavir and enfuvirtide in a pregnant woman

Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up

A global call for action to include gender in research impact assessment

Dual therapy (ritonavir boosted atazanavir + raltegravir) versus standard triple therapy (ritonavir boosted atazanavir + tenofovir/emtricitabine) in patients failing first line therapy: 48 week results from a randomized pilot study

Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI

Functionality of CD8+ T-cells in subjects under cART: implications on cure strategies

HIV and neglected infectious diseases in Latin America and the Caribbean: issues and challenges for knowing the burden of co-infection

Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy

Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain)

Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality

Self-reported cART adherence and alcohol, tobacco, and illicit drug use in a cohort of HIV-infected patients in Buenos Aires

Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area

Suchergebnisse filtern